RenalGuard
by RenalGuard Solutions, Inc.
RenalGuard Therapy®
A Therapeutic Approach to Reducing Contrast-Induced Nephropathy
RenalGuard Therapy® is designed to reduce the toxic effects that contrast media can have on the kidneys, which may lead to a reduction in the incidence of Contrast-Induced Nephropathy (CIN) in at-risk patients. This therapy is based on existing published literature, including the PRINCE study1, which support the theory that creating and maintaining a high urine output through the kidneys allows the body to rapidly eliminate contrast, reducing its toxic effects.
RenalGuard Therapy entails the use of a physician-prescribed loop diuretic which may induce the required high urine output. RenalGuard System is designed to measure urine output and replaces it in real-time with an equal volume of sterile saline. This matched fluid replacement aims to minimize the risk of over- or under-hydration which can lead to increased patient risks.
Highest level of customer service and support.
The founders of EPS Vascular have over fifty years of combined experience in the cardiovascular business and pride themselves on providing the highest level of customer service and support.
Our Partners
